| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年4月 |
Humanized Mouse and Rat Models Market – Global Forecast to 2030
The global humanized mouse and rat model market is anticipated to reach USD 409.8 million in 2030 from USD 276.2 million in 2025, with a significant CAGR of 8.2%.
世界のヒト化マウス・ラットモデル市場は、2025年の2億7,620万米ドルから2030年には4億980万米ドルに達し、8.2%という大幅なCAGRで成長すると予想されています。
The market is growing strongly at a high CAGR due to rising R&D investments of pharmaceutical and biopharmaceutical firms. As the pipeline of R&D expands, the requirement for outsourcing analytical testing is set to rise, in addition to the research initiatives on rare diseases and orphan drugs. Furthermore, the high costs of in-house drug development have also contributed to this trend. Industry players will likely witness healthy growth opportunities due to technological advancements, new drug discovery techniques, patent expirations, and rising demand for specialized testing services among end users.
製薬企業およびバイオ医薬品企業による研究開発投資の増加により、市場は高いCAGRで力強く成長しています。研究開発パイプラインの拡大に伴い、希少疾患やオーファンドラッグに関する研究活動に加え、分析試験のアウトソーシング需要も増加すると予想されます。さらに、自社開発における医薬品開発コストの高騰もこの傾向に拍車をかけています。業界関係者は、技術の進歩、新たな創薬技術、特許満了、そしてエンドユーザーによる専門的な試験サービスへの需要の高まりにより、健全な成長機会を享受できる可能性が高いでしょう。
Charles River Laboratories (US), The Jackson Laboratory (JAX) (US), Taconic Biosciences, Inc. (US), JSR Corporation (US) (Crown Biosciences), Champions Oncology, Inc. (US), CLEA Japan Inc. (Japan), genOway (France), Inotiv (US), Janvier Labs (France), Altogen Labs (US), Vitalstar Biotechnology (China), Ingenious Targeting Laboratory (US), Reaction Biology (US), Harbour BioMed (Netherlands), Oncodesign Services (France), Pharmatest Services (Finland), Ozgene Pty Ltd. (Australia), TransCure bioServices (France), Cyagen Biosciences (US), Aragen Life Sciences Ltd. (India), GemPharmatech (China), and Biocytogen (US) are some of the key players in the humanized mouse and rat model market.
The report provides insights on the following pointers:
- Analysis of key drivers (rising use of humanized models in drug discovery research, emerging preclinical applications of humanized mouse models, government-funded initiatives for cancer research, and increasing R&D activities in the pharmaceutical & biotechnology industry), restraints (introduction of FDA Modernization Act 2.0/3.0, stringent regulatory compliance for ethical use of animal models), opportunities (growing preference for humanized PDX models, emergence of CRISPR in biomedical research), and challenges (alternatives for animal testing, limitations of humanized mouse models) influencing market growth.
- Product Development/Innovation: Detailed insights on upcoming technologies in humanized mouse and rat models, research and development activities, and new product launches in the humanized mouse and rat model market.
- Market Development: Comprehensive information about lucrative markets—the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the humanized mouse and rat model market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Charles River Laboratories (US), The Jackson Laboratory (JAX) (US), Inotiv (US), and genOway (France).